Literature DB >> 30389523

c-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma.

Xichun Xiao1, Yueli Gu1, Genjie Wang1, Shuxia Chen2.   

Abstract

Long non-coding RNA (lncRNA) component of mitochondrial RNA processing endoribonuclease (RMRP) has been demonstrated to be implicated in human cancer processes. However, the role of lncRNA RMRP in multiple myeloma (MM) remains unknown. In this paper, we proved that RMRP and c-Myc were upregulated, while miR-34a-5p was downregulated in MM cell lines and bone marrows of MM patients. High RMRP expression significantly correlated with worse disease-free survival and overall survival in MM patients. c-Myc promoted RMRP transcription by directly binding to its promoter region. Knockdown of RMRP inhibited proliferation and promoted apoptosis of OPM2 and RPMI-8226 cells. Negative correlation between RMRP, and miR-34a-5p was discovered in bone marrows of MM patients. c-Myc expression was inversely correlated with miR-34a-5p in bone marrows of MM patients. Additionally, silencing of RMRP led to a marked reduction in c-Myc expression in OPM2 and RPMI-8226 cells, and this action was obviously blocked by miR-34a-5p knockdown. Moreover, upregulation of miR-34a-5p repressed proliferation and promoted apoptosis of OPM2 and RPMI-8226 cells. However, RMRP overexpression blocked these changes triggered by miR-34a-5p mimic. Besides, RMRP knockdown repressed MM tumor growth in vivo. Conclusions, RMRP functions as a miR-34a-5p sponge to promote cell proliferation and repress cell apoptosis through upregulation of c-Myc in MM.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Multiple myeloma; c-Myc; miR-34a-5p

Mesh:

Substances:

Year:  2018        PMID: 30389523     DOI: 10.1016/j.ijbiomac.2018.10.207

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  24 in total

Review 1.  Long non-coding RNAs and MYC association in hematological malignancies.

Authors:  Leonidas Benetatos; Agapi Benetatou; Georgios Vartholomatos
Journal:  Ann Hematol       Date:  2020-07-04       Impact factor: 3.673

2.  In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma.

Authors:  Somnath Ghosal; Subrata Banerjee
Journal:  Med Oncol       Date:  2022-02-12       Impact factor: 3.064

3.  Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition.

Authors:  Maryam Hosseini; Kaveh Baghaei; Davar Amani; Masoumeh Ebtekar
Journal:  Daru       Date:  2021-08-17       Impact factor: 4.088

4.  Isoflurane preconditioning protects hepatocytes from oxygen glucose deprivation injury by regulating FoxO6.

Authors:  Yonghui Zhong; Xuefang Hu; Liangsheng Miao
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

5.  [miR-34a-5p regulates viability, invasion and apoptosis of placental trophoblastic cells via modulating CDK6 and PI3K/AKT pathway].

Authors:  Qin Li; Juanxiu Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-01-30

Review 6.  LncRNAs in adaptive immunity: role in physiological and pathological conditions.

Authors:  Pedro Faria Zeni; Marek Mraz
Journal:  RNA Biol       Date:  2020-11-09       Impact factor: 4.652

Review 7.  RNA polymerase III transcription as a disease factor.

Authors:  Meghdad Yeganeh; Nouria Hernandez
Journal:  Genes Dev       Date:  2020-07-01       Impact factor: 11.361

8.  Long noncoding-RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA-217.

Authors:  Lingyu Tang; Yuting Wang; Huishan Wang; Boming Xu; Hao Ji; Guolong Xu; Xianxiu Ge; Quanpeng Li; Lin Miao
Journal:  Cancer Sci       Date:  2019-06-28       Impact factor: 6.716

9.  LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro.

Authors:  Shanshan Huang; Zhengyu Zhan; Li Li; Hui Guo; Yangyang Yao; Miao Feng; Jun Deng; Jianping Xiong
Journal:  Onco Targets Ther       Date:  2019-07-24       Impact factor: 4.147

10.  Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.

Authors:  Yunhui Xiang; Liuyun Zhang; Pinpin Xiang; Juan Zhang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.